Dhaka | Sunday | 18th of April 2021 | Bangla Version | Get Our App EN
  • TOP STORIESTOP STORIES
    •
  • WORLD
  • BANGLADESH
  • INDIA
    •
  • ECONOMY
  • TECH
  • SPORTS
    •
  • CULTURE
    •
  • ♦ MORE ♦
  • ♦ MORE LINK ♦
    • NBS » 2-Headlines » Breaking: Covid-19: Interim clinical efficacy of Covaxin is 81%, says Bharat Biotech | India News
    TODAY'S ALL NEWS
    Previous
    Next


    Please subscribe to NBS YouTube channel:

    Breaking: Covid-19: Interim clinical efficacy of Covaxin is 81%, says Bharat Biotech | India News
    NBS | Wednesday, March 3rd, 2021 | Published: 11:58 pm

    Breaking: Covid-19: Interim clinical efficacy of Covaxin is 81%, says Bharat Biotech | India News

    Dear viewer, click on the link below to read the details of this news.

    2021-03-03 23:58:12

    India News | Latest News Headlines & Live Updates from India – Times of India

    Read on the original site

    timesofindia.indiatimes.com


    TODAY'S ALL NEWS

    Write your comment...
    NBS24 News

    nbs24new3 © All Rights Reserved
    News Broadcasting Service - NBS
    (NBS) 2015 - 2020

    CEO: Abdullah Al Masum,
    Editor and Publisher : Sultana Rabiya
    -------------------------------------------
    Bangshal, Dhaka-1000, Bangladesh.
    Cell : +88 02 , +88 01718 580 689
    Email : [email protected], [email protected]

    USA Office: 41-11, 28th Avenue, Suite # 15 (3rd floor), Astoria, New York-11103,
    United States of America. Cell: 917-396-5705.

    Prasenjit Das, Editor in Chief, India.
    Address : Central Road, Town Pratapgarh, Agartala, Tripura, India. +919402109140.

    Home l About NBS l Contact the NBS l DMCA l Terms of use l Advertising Rate l Sitemap l Live TV l All Paper

    Reproduction of content, news or article published on this nbs website is strictly prohibited. - Privacy Policy